This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...
Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.
A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...
We're living in a world full of foods that trigger constant hunger, cravings and thoughts about eating. Is it even possible ...
Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...
GLP-1s seem to be everywhere. The appetite suppressant drugs, with brand names like Ozempic and Wegovy, have grown in ...
Regulatory watchdog South African Health Products Regulatory Authority said these types of products pose a health risk to the public.
Ozempic could be behind a “concerning” return of skinny models, the editor of British Vogue magazine has said. Chioma Nnadi ...
No matter how much she ate, she never felt satisfied. But after starting a non-FDA approved GLP-1 agonist—an injectable drug ...